Subtype
Urinary Tract Neoplasm
CI-CAN-00001627Explore in graph →
Non-malignant558 active trials14 approved drugs29 evidence items
Loading cancer entity…
Subtype
CI-CAN-00001627Explore in graph →
Clinical trials
2,186 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT05643690 | Urine Sample Collection for Validation of the AnchorDx UriFind™ Bladder Cancer Assay | suspended | — | 77 | AnchorDx Medical Co. Ltd. USINDUSTRY | 1 | Jun 6, 2024 | clinicaltrials |
| NCT02607709 | Lymphadenectomy in Urothelial Carcinoma | suspended | N/A | 366 | Zealand University HospitalOTHER | 1 | Jan 30, 2024 | clinicaltrials |
Showing 1–2 of 2 studies
Data updated 22 days agoSource updated Jun 6, 2024source: clinicaltrials